Human Vaccines & Immunotherapeutics

Papers
(The TQCC of Human Vaccines & Immunotherapeutics is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Human vaccines & immunotherapeutics: News October 2022175
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China121
Human vaccines and immunotherapeutics: News December 2023120
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She110
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study106
Healthcare workers’ and caregivers’ knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu84
Determinants of basic childhood vaccination coverage in European and OECD countries82
Enhancing COVID-19 booster vaccination among the elderly through text message reminders80
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control73
Drivers and barriers to influenza vaccination in the post–COVID-19 era in the Federation of Bosnia and Herzegovina: A qualitative study using focus groups with risk groups and in-depth interviews with69
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak68
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance68
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study68
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children67
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality66
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain65
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China64
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have63
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia59
Depemokimab: A twice yearly anti–IL 5 biologic for chronic rhinosinusitis with nasal polyps (CRSwNP) – A narrative review57
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study57
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies56
HPV vaccination scenario and parental willingness to pay among girls aged 9–14 y in the Yangtze River Delta, China52
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam49
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities49
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector48
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer48
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children46
A novel anti-PcrV monoclonal antibody inhibits toxin-mediated cytotoxicity and enhances survival in mouse models of Pseudomonas aeruginosa infection46
Acceptability of patient-centered digital vaccine safety monitoring: A Canadian Immunization Research Network study44
Age- and time-dependent waning vaccine effectiveness of PPV23 against community-acquired pneumonia among adults aged 60 and older: A cohort study42
Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals42
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature41
Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines40
The effect of preexisting antibodies from Tdap vaccination during pregnancy on infant antibody responses to the pertussis-containing vaccines40
Associations between vaccination clinic factors and DTaP dropout in China: A cross-sectional study40
A Bayesian re-analysis of the DANFLU-1 trial38
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention38
A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals38
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children38
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges37
Pertactin deficiency of Bordetella pertussis : Insights into epidemiology, and perspectives on surveillance and public health impact37
HV&I Reviewer Highlight35
Bacteriophages as vaccine platforms: Opportunities and challenges in translation35
Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy35
Factors associated with willingness to accept pneumococcal vaccine based on the Health Belief Model among the elderly (≥60 years) living in Klang Valley, Malaysia35
PV-10 enhances immune responses in hepatitis B vaccination through STING pathway35
Monitoring the safety of the adjuvanted human papillomavirus vaccine HPV-16/18-AS04 in association with pregnancy and potential immune-related diseases in China: A retrospective observational cohort s35
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer34
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies34
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons34
Improving Tdap maternal immunization rate in Saudi Arabia34
How to make effective HPV vaccine recommendations starting at age 934
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria33
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)33
Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–202533
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents32
Adverse events after COVID-19 vaccination self-reported by healthcare workers are reliable32
Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China32
Determinants of seasonal influenza and COVID-19 vaccine uptake in high-risk individuals in northern Sweden32
HV&I Reviewer Highlight32
“Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”32
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary32
Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)32
CEA vaccines32
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 202132
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial31
Statistical and machine learning methods for immunoprofiling based on single-cell data31
The role of age, sex, and ethnicity in vaccine trust, and sources of information in Canada: Findings from a national survey30
A review of technological developments in lipid nanoparticle application for mRNA vaccination30
An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination30
Risk and safety profile in checkpoint inhibitors on non-small-cell lung cancer: A systematic review30
Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus29
COVID-19 vaccine acceptance in three rural communes in Haiti: A cross-sectional study29
Autologous engineered T cell receptor therapy in advanced cancer29
Public health impact of herpes zoster vaccination on older adults in Hong Kong29
Vaccine literacy among Italian travelers: A web-based survey using a brief assessment tool29
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine28
Analysis on the characteristics of delayed EV71 vaccination among children in the birth cohort from 2017 to 202228
Vaccine confidence and information sources among children and adolescents: A national cross-sectional survey28
Influenza vaccination landscape in Italy: A comprehensive study through the OBVIOUS project lens27
Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis27
The efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A meta-analysis and reconstructed individual patient data analysis27
Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional study27
Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review26
Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6–35 months of age in China: A randomized, double-blind, clinical trial26
A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT)26
The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer26
Validation of self-reported human papillomavirus vaccination in young adult men who have sex with men26
Another measles outbreak in the Philippines? The essentiality of a successful vaccination program and public cooperation26
Access to a protected setting vaccination for allergic patients: Evaluation of appropriateness. The experience of Bari Policlinico University Hospital26
Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 years26
Misconceptions and knowledge gaps about HPV, cervical cancer, and HPV vaccination among Central American immigrant parents in the United States25
A video-based educational intervention to improve vaccine acceptance for Schistosomiasis japonicum: A pre–post study using the 5C model in rural China25
Herpes zoster vaccination and vaccine preferences among persons aged 50–64 years in Australia: Findings from a discrete choice experiment25
The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country25
Development of a herpes zoster vaccination intention scale and identification of factors associated with vaccine hesitancy among middle-aged and older attendees in community health centers: A Protecti25
Retrospective cohort study of mRNA COVID-19 vaccine-associated enhanced disease in the Vaccine Safety Datalink, 2021–2324
Immunotherapy in pediatric bone sarcomas: Current progress and future directions24
“They were saying that it’s the end of the world”: Experiences of COVID-19 and beliefs about the COVID-19 vaccine among refugees in Rhode Island, US24
Analysis on the epidemiological characteristics of varicella and breakthrough case from 2014 to 2022 in Qingyang City24
Multilevel perspectives on school-based opportunities to improve HPV vaccination among medically underserved adolescents: Beyond school entry mandates24
Evaluating the cost-effectiveness of adjuvanted influenza vaccine in the older adult population in the Netherlands24
Bibliometric and visual analysis of vaccination hesitancy research from 2013 to 202224
Human Papillomavirus vaccine knowledge and recommendation practice among primary care providers, Almaty, Kazakhstan – 202324
Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China24
Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 201923
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized control23
State of pneumococcal vaccine immunity23
Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors23
Impact of immunization strategies, public health and social measures on the incidence of varicella among children aged 0–14 years in Quzhou City23
Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy23
Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China23
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States23
Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer23
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults22
Disparities in full immunization coverage among urban and rural children aged 12-23 months in southwest Ethiopia: A comparative cross-sectional study22
Human vaccines and immunotherapeutics: News July 202522
Artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis of the landscape22
Exploring mother-daughter communication and social media influence on HPV vaccine refusal for daughters aged 9-17 years in a cross-sectional survey of 11,728 mothers in China22
Economic and epidemiological burden of HPV-related diseases in the Czech Republic: A claims database analysis22
BC02-adjuvanted varicella-zoster virus glycoprotein E subunit vaccine overcomes immunosenescence to induce robust neutralizing antibodies and multifunctional T-cell immunity in seropositive aged murin22
Vaccine hesitancy in the refugee, immigrant, and migrant population in the United States: A systematic review and meta-analysis22
Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers22
Elranatamab: A novel B-cell maturation T-cell engager22
Meningococcal vaccine information on YouTube in Türkiye: A cross-sectional analysis of content quality and reliability22
Determinants of immunization defaulters among children aged 12–23 months in Ambo town, Oromia, Ethiopia: A case–control study22
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale21
HV&I reviewer highlight21
COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis21
Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword21
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?21
Comment on “Bidirectional crosstalk between the epithelial-mesenchymal transition and immunotherapy: A bibliometric study”21
Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 221
Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy21
Effect of difference between EV-A71 virus epidemic strain and “vaccine strain” on neutralizing antibody titer21
Response to Letter to the Editor by Amnuay Kleebayoon, Viroj Wiwanitkit titled: Hesitancy toward vaccination against COVID-1920
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial20
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial20
2024 List of Reviewers20
Analysis on willingness and its influencing factors of influenza vaccination among HCWs in Quzhou in 2022–2023 influenza season20
Human papillomavirus (HPV) vaccine clinical trials: A cross-sectional analysis of clinical trials registries20
Vaccine hesitancy and its determinants among refugee parents resettled in Aotearoa New Zealand20
Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination20
Respiratory syncytial virus immunization with nirsevimab: Acceptance and satisfaction assessment in infants and risk groups in the region of Murcia (Spain)20
Correlates of uptake of COVID-19 vaccines and motivation to vaccinate among Malawian adults19
Changes in 23-valent pneumococcal polysaccharide vaccination rate and associated factors in 2022 and 2024 among community-based older adults in Shanghai, China19
Overcoming barriers to HPV vaccination in rural Vermont through a multicomponent peer-based approach19
Spatiotemporal distribution and determinants of immunization among children aged 12–23 months in Ethiopia: Using EDHS 2000, 2005, 2011, and 201619
Management of MOG antibody-associated disease by pembrolizumab and radiation myelopathy in an elderly patient: A case report and literature review19
Immunogenicity, safety, and tolerability of a β-glucan-CpG-adjuvanted respiratory syncytial virus vaccine in Japanese healthy participants aged 60 to 80 years: A phase 2, randomized, double-blind, dos19
Seroepidemiological survey of the population 10 years after the implementation of the varicella vaccine 2-dose immunization strategy19
Safety Surveillance for Hepatitis A Vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database19
Factors influencing attitudes toward vaccine safety and vaccine effectiveness amongst UK healthcare professionals prior to and at the time of COVID-19 vaccine rollout: Insights from the CoPE-HCP cohor19
Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return19
Immunogenicity persistence after four intramuscular triple-dose or standard-dose hepatitis B vaccine in patients receiving methadone maintenance treatment: A 1-year follow-up study in China19
Seasonal influenza vaccination uptake among health and medical college students: A discrete choice experiment19
A retrospective audit of neonatal BCG vaccination in Grampian, Scotland19
Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings19
Survey of pediatricians concerning the human papillomavirus vaccine in Japan: Positive attitudes toward vaccination during the period of proactive recommendation being withheld19
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective19
“Same principles, different decisions”: A qualitative study exploring the attitudes of COVID-19 vaccination among school staff in Switzerland19
Modifying non-coding regions of linear DNA vaccines to explore the interplay of expression and inflammation in immunogenicity19
A community-wide epidemic of hepatitis A virus genotype IA associated with consumption of shellfish in Yantai, eastern China, January to March 202018
Comparing factors influencing seasonal influenza vaccine acceptance and intentions among Chinese university students residing in China and UK: A cross-sectional study18
Immunity gap for measles in young adults: Seroprevalence study in blood donors in southern Italy18
Advancements in the development of nucleic acid vaccines for syphilis prevention and control18
Causal associations between antibody-mediated immune responses to infectious agents and cardiovascular inflammatory diseases: A Mendelian randomization study based on UK Biobank and FinnGen18
Is vaccine hesitancy related to mental health after the adjustment of the zero-COVID-19 strategy in the elderly? A mediation analysis in China18
Pneumonia hospitalizations of children aged <2 years in Poland before (2013–2016) and after (2017–2018) universal mass vaccination with 10-valent pneumococcal non-typeable Haemophilu18
Parental intention on getting children COVID-19 vaccinations: Invariance evaluation across parenting roles and COVID-19-like symptoms experiences among Iranians during the pandemic period18
Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination18
Rescuing age-associated vaccine hyporesponsiveness in murine and nonhuman primate models with an immunostimulatory vaccine adjuvant18
Mpox vaccination hesitancy and its associated factors among the general population in China: A national observational study18
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer18
Transmission patterns of pertussis in school-based clustered outbreaks: A retrospective analysis in Zhejiang Province, China, 202418
Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity18
The attitude and knowledge of pediatricians and family physicians toward COVID-19 vaccination in children: A cross-sectional study18
Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report18
Comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”18
A study on the willingness and influencing factors of non-EPI vaccines recommendations among Chinese vaccination staff under major infectious disease outbreaks17
A systematic review of gastritis as an immune-related adverse event in clinical interventions17
Human vaccines & immunotherapeutics: News December 202217
Response to comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”17
COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study17
The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis17
Diverse processes in rotavirus vaccine development17
Cost-effectiveness of a behavioral insights-informed digital campaign to increase HPV vaccination in Bangladesh17
Closer adult child–parent relations the stronger the vaccine hesitancy: A cross-sectional study of adult Children’s attitudes toward pneumococcal vaccination of elderly parents and its determinants in17
Enhancing routine immunization efforts for older adults and frail individuals: Good practices during the SARS-CoV-2 pandemic in Italy17
Correction17
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus17
11th Immunotherapy of Cancer conference (ITOC): A meeting report17
Exploring nurses’ experiences with a school-located influenza vaccination program: A qualitative study in the region of Murcia, Spain17
Development of mRNA rabies vaccines17
Reframing evidence on the BCG vaccine: What emerging systematic reviews and meta-analyses reveal about efficacy, safety, and heterogeneity17
Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects17
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study17
Vaccination in the shadow of uncertainty: Exploring the links between government trust and COVID-19 vaccine acceptance17
Economic burden of respiratory syncytial virus disease in Latin America: A systematic review16
Malawi vaccination drive: An integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges16
Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan16
Bibliometric analysis on the progress of immunotherapy in renal cell carcinoma from 2003-202216
Antibody levels and immune memory in children with kaposiform hemangioendothelioma treated with sirolimus after catch up vaccination16
COVID-19 vaccination up-take in three districts of Nepal16
Immunogenicity and safety of the non-typable Haemophilus influenzaeMoraxella catarrhalis (NTHi-Mcat) vaccine administered following the16
The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance16
Establishment of the 1st Chinese national standard for CA6 neutralizing antibody16
Proportion of births protected against neonatal tetanus and its associated factors among mothers who gave birth within the past 6 months in Gozamn district, Northwest Ethiopia, 202216
Misinformation and COVID-19 vaccine uptake hesitancy among frontline workers in Tanzania: Do demographic variables matter?16
Determinants of parental self-reported uptake of influenza vaccination in preschool children during the COVID-19 pandemic16
Analysis of public opinion polls about COVID-19 vaccines: Theoretical and policy implications for vaccine communication and campaigns to address vaccine hesitancy16
Correction16
Efficacy of vaccination against the SARS-CoV-2 virus in patients with chronic kidney disease on hemodialysis16
Bibliometric analysis of dendritic cell-based vaccines over the past 15 years16
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Europe and the Middle East in the post-licensure period16
Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated16
Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner15
Real-world single-center data analysis of dual immunotherapy in advanced NSCLC: Efficacy, survival, and adverse events15
Exploring the availability and content of vaccinology courses across the globe: A scoping review15
Socioeconomic inequality in second-dose measles vaccination dropout among children aged 15–35 months in East Africa: A decomposition analysis of a recent Demographic Health Survey15
Review of bimekizumab in the treatment of psoriasis15
Changes in dendritic complexity and spine morphology following BCG immunization in APP/PS1 mice15
Documented vaccination as proof of immunity compared to serology in medical students15
The complicated use of dupilumab in the treatment of atypical generalized pemphigus erythematosus: A report of two cases15
Parental intention to vaccinate children against seasonal influenza in the Eastern Mediterranean region: A cross-sectional study using the health belief model15
Outbreak report of rotavirus gastroenteritis among remotely vaccinated travelers: A potential implication of booster vaccine for travelers to endemic countries15
Mothers’ perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds15
Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–215
Opportunities for HPV vaccine education in school-based immunization programs in British Columbia, Canada: A qualitative study15
Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines15
Human vaccines & immunotherapeutics: News March 202315
Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain15
The safety and immunogenicity of inactivated rotavirus vaccine delivered by a dissolving microneedle patch in rats15
Efficacy and safety analysis of immune checkpoint inhibitor rechallenge in advanced esophageal squamous cell carcinoma: A retrospective study15
Hyponatremia predicts immunotherapy resistance in biliary tract cancer15
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis15
Assessment of knowledge, attitudes, and behaviors regarding vaccinations among LGBTQIA+ community in Italy15
Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine15
A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma15
Clinical and economic burden of herpes zoster in Mexico: A retrospective medical chart analysis in a private healthcare setting15
Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases15
Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial14
Navigating vaccine hesitancy: Strategies and dynamics in healthcare professional-parent communication14
COVID-19 vaccine acceptance and its association with knowledge and attitude among patients with chronic diseases in Ethiopia14
Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or infection: A national cohort study using linked electronic health records14
Protein nanocages: A new frontier in mucosal vaccine delivery and immune activation14
Response to comment on ‘Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study’14
Commentary: Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013–202214
Current updates on generations, approvals, and clinical trials of CAR T-cell therapy14
0.25439190864563